Related Experiment Video
Updated: Apr 26, 2026

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
Metabolically healthy obesity--does it exist?
Patchaya Boonchaya-anant1, Caroline M Apovian
1Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University School of Medicine, Robinson Building 4400, 88 East Newton Street, Boston Medical Center, Boston, MA, 02118, USA, b_patchaya@yahoo.com.
Metabolically healthy obesity (MHO) affects 20-30% of obese individuals, presenting normal metabolic profiles despite excess weight. This review explores MHO characteristics, contrasts them with metabolically unhealthy obesity, and examines underlying biological mechanisms.
Area of Science:
- Obesity research
- Metabolic health
- Public health
Background:
- Global obesity rates have surged in recent decades, posing significant public health challenges.
- Obesity is typically linked to metabolic issues like insulin resistance and inflammation.
- A distinct subgroup, metabolically healthy obese (MHO), exhibits normal metabolic parameters despite obesity.
Purpose of the Study:
- To define the metabolically healthy obese (MHO) phenotype.
- To differentiate MHO individuals from metabolically unhealthy obese (MUO) individuals.
- To investigate potential biological mechanisms underlying MHO.
Main Methods:
- Literature review of studies on obesity and metabolic health.
- Comparative analysis of MHO and MUO phenotypes.
- Exploration of cellular and molecular mechanisms.
Main Results:
- MHO individuals are characterized by high insulin sensitivity and lack of diabetes, dyslipidemia, or hypertension.
- Prevalence of MHO ranges from 20% to 30% among obese populations.
- Key differentiating factors between MHO and MUO are being investigated.
Conclusions:
- The MHO phenotype represents a significant subset of individuals with obesity.
- Understanding MHO mechanisms is crucial for targeted health interventions.
- Further research into adipocyte differentiation, immune regulation, and energy metabolism is warranted.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
What is Metabolism?

